Mayukh Sukhatme Roivant Sciences Ltd. (ROIV) insider trading activity

ROIV Quotes by TradingView

Mayukh Sukhatme is President & CIO of Roivant Sciences Ltd.. Currently has a direct ownership of 18.8 Million shares of ROIV, which is worth approximately $382 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 32,682 shares (Common Shares) at a price of $23.09 per share, resulting in proceeds of $754,627. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.8M
0% 3M change
0% 12M change
Total Value Held $382 Million

Mayukh Sukhatme Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2025
SELL
Other acquisition or disposition
$754,627 $23.09 p/Share
32,682 Reduced 0.17%
18,836,547 Common Shares
Dec 17 2025
SELL
Open market or private sale
$619,527 $23.09 p/Share
26,831 Reduced 0.14%
18,869,229 Common Shares
Dec 17 2025
BUY
Exercise of conversion of derivative security
$754,624 $12.68 p/Share
59,513 Added 0.31%
18,896,060 Common Shares
Dec 26 2024
SELL
Open market or private sale
$8,280,834 $12.01 p/Share
689,495 Reduced 3.53%
18,836,547 Common Shares
Dec 26 2024
BUY
Exercise of conversion of derivative security
$2,654,555 $3.85 p/Share
689,495 Added 3.41%
19,526,042 Common Shares
Dec 24 2024
SELL
Open market or private sale
$2,231,352 $12.0 p/Share
185,946 Reduced 0.98%
18,836,547 Common Shares
Dec 24 2024
BUY
Exercise of conversion of derivative security
$715,892 $3.85 p/Share
185,946 Added 0.97%
19,022,493 Common Shares
Dec 23 2024
SELL
Open market or private sale
$129,552 $12.0 p/Share
10,796 Reduced 0.06%
18,836,547 Common Shares
Dec 23 2024
BUY
Exercise of conversion of derivative security
$41,564 $3.85 p/Share
10,796 Added 0.06%
18,847,343 Common Shares
Dec 18 2024
SELL
Open market or private sale
$4,971,637 $12.05 p/Share
412,584 Reduced 2.14%
18,836,547 Common Shares
Dec 18 2024
BUY
Exercise of conversion of derivative security
$1,588,448 $3.85 p/Share
412,584 Added 2.1%
19,249,131 Common Shares
Dec 03 2024
SELL
Other acquisition or disposition
$44,590,736 $12.21 p/Share
3,651,985 Reduced 16.24%
18,836,547 Common Shares
Jul 26 2024
BUY
Grant, award, or other acquisition
-
18,836,547 Added 45.58%
22,488,532 Common Shares
Mar 30 2024
SELL
Payment of exercise price or tax liability
$3,859,863 $10.54 p/Share
366,211 Reduced 9.11%
3,651,985 Common Shares
Mar 30 2024
BUY
Exercise of conversion of derivative security
-
729,081 Added 15.36%
4,018,196 Common Shares
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
71,365 Added 2.12%
3,289,115 Common Shares
Sep 27 2023
BUY
Exercise of conversion of derivative security
-
27,790 Added 0.86%
3,217,750 Common Shares
Aug 27 2023
BUY
Exercise of conversion of derivative security
-
22,565 Added 0.7%
3,189,960 Common Shares
Jul 27 2023
BUY
Exercise of conversion of derivative security
-
43,212 Added 1.35%
3,167,395 Common Shares
May 27 2023
BUY
Exercise of conversion of derivative security
-
99,458 Added 3.09%
3,124,183 Common Shares
MS

Mayukh Sukhatme

President & CIO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ROIV